17q12 microduplication syndrome

17q12 microduplication syndrome (also known as chromosome 17q12 duplication syndrome) is a rare chromosomal disorder caused by a duplication of a small segment of genetic material on the long arm of chromosome 17, spanning approximately 1.4 megabases. This region includes the HNF1B gene and several other genes. The syndrome is characterized by a highly variable clinical presentation, which can make diagnosis challenging. The 17q12 duplication is considered a susceptibility locus for neurodevelopmental and neuropsychiatric disorders rather than a fully penetrant condition, meaning that some carriers may have minimal or no symptoms. The most commonly reported features include intellectual disability (often mild), developmental delay, speech and language delays, and behavioral abnormalities. Neuropsychiatric manifestations are prominent and may include autism spectrum disorder, attention deficit hyperactivity disorder (ADHD), schizophrenia, and other psychiatric conditions. Epilepsy has also been reported in some individuals. Dysmorphic facial features may be present but are typically subtle and non-specific. Some individuals may have additional features such as microcephaly, failure to thrive, or minor congenital anomalies, though the phenotype is broadly variable. Notably, the duplication can be inherited from an apparently unaffected parent, highlighting the reduced penetrance of this condition. There is currently no specific cure or targeted therapy for 17q12 microduplication syndrome. Management is supportive and symptom-based, involving early intervention programs, speech therapy, occupational therapy, behavioral therapy, and educational support. Neuropsychiatric symptoms are managed with standard pharmacological and behavioral approaches. Regular developmental and neuropsychological assessments are recommended. Genetic counseling is important for affected individuals and their families to understand the variable expressivity and inheritance implications of this condition.

Common questions about 17q12 microduplication syndrome